Riskpilot← Back to searchSign inGet full accessFINSNES INVEST AS
ASActiveOrg 989112813Kirkegate 48, 4006 StavangerOther human health activities n.e.c. · NACE 8699Est. 20060 employees
Revenue 2024
NOK 1,4M
+27% vs 2023
EBITDA margin
56.8%
+128% vs 2023
Equity ratio
59.5%
Financial strength
Net profit 2024
NOK 53,8M
+36% vs 2023
| Revenue | NOK 1,4M | +27% |
| EBITDA | NOK 800K | +128% |
| Net profit | NOK 53,8M | +36% |
| Total assets | NOK 349,1M | +18% |
| Equity | NOK 207,6M | +35% |
| Employees | 0 | — |
Legal name
FINSNES INVEST AS
Org number
989112813
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
8. februar 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i andre virksomheter.
Address
Kirkegate 48, 4006 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 370 | 1 564 | 1 199 | 1 105 | 1 408 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −1 625 | 708 | 411 | −2 861 | 800 |
| Depreciation & amort. | −0 | −280 | −292 | −230 | −585 |
| EBIT | −1 625 | 428 | 119 | −3 091 | 215 |
| Net financials | −1 987 | 17 441 | 49 966 | 42 385 | 54 083 |
| Profit before tax | −3 612 | 17 869 | 50 085 | 39 294 | 54 298 |
| Tax | −155 | 171 | −419 | −367 | 515 |
| Net profit | −3 457 | 17 698 | 50 504 | 39 661 | 53 783 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 127 855 | 166 313 | 257 888 | 296 200 | 349 085 |
| Equity | 46 376 | 64 074 | 114 578 | 153 795 | 207 578 |
| Long-term debt | 34 264 | 53 821 | 50 651 | 47 347 | 40 457 |
| Short-term debt | 47 214 | 48 418 | 92 659 | 95 059 | 101 050 |
| Total debt | 81 478 | 102 239 | 143 310 | 142 406 | 141 507 |
EBITDA margin
56.8%
This company
15.8%
Market median
+259% vs market
20202024
Equity ratio
59.5%
This company
38.2%
Market median
+56% vs market
20202024
Return on equity
25.9%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
3819.9%
This company
8.1%
Market median
+47059% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FF Deputy Member | Deputy Member | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2009 | |
| Deputy Chairman | 2009 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FINSNES INVEST AS 
ENDOTELIN ASBoard members of FINSNES INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Finsnes | Deputy Member | 0 companies |
| Finn Finsnes | Chairman | 0 companies |
| Christine Lindeman Finsnes | Deputy Chairman | 0 companies |